Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 141.9B | 137.4B | 141.4B | 125.9B |
| Cost of revenue | 85.4B | 68.4B | 69.7B | 62.8B |
| Gross profit | 56.5B | 69.0B | 71.7B | 63.1B |
| Operating expense | ||||
| Research & development | 35.0B | 31.9B | 31.6B | 30.2B |
| Selling general and admin | 18.3B | 16.4B | 14.6B | 13.3B |
| Other operating expenses | — | — | -203.1M | -258.5M |
| Operating income | -2.5B | 14.9B | 19.5B | 13.4B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 701.7M | 369.3M | 350.9M | 424.7M |
| Other income expense | 1.8B | 720.2M | -6.1B | 664.8M |
| Pretax income | -1.4B | 15.2B | 16.4B | 13.6B |
| Tax provision | -15.4B | 2.3B | 7.7B | -498.6M |
| Net income | 16.1B | 13.1B | 8.9B | 14.2B |
| Basic EPS | 0.5 | 0.4 | 0.3 | 0.5 |
| Diluted EPS | 0.5 | 0.4 | 0.3 | 0.5 |
| Basic average shares | 30.0B | 29.9B | 30.0B | 29.9B |
| Diluted average shares | 30.1B | 30.0B | 30.2B | 30.2B |
| EBITDA | 13.3B | 29.3B | 31.3B | 29.5B |
| Net income from continuing op. | 14.2B | 13.1B | 8.9B | 14.2B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |